Industry: Medical Devices & Consumables
Published Date: 2024-08-16
Pages: 82 Pages
Report ld: 3282427
Request Sample
Customized Report
Micronized Acellular Dermal Matrix (mADM) is a biocompatible material derived from human or animal dermis, which has been processed to remove cellular components while preserving the extracellular matrix structure. The micronization process involves breaking down the acellular dermal matrix into smaller particles, which can be formulated into a paste or injectable form. This matrix serves as a scaffold that supports tissue regeneration and repair by promoting cell infiltration and neovascularization. mADM is particularly used in wound healing, as it provides a structural framework that facilitates the closure of difficult-to-heal wounds, such as those resulting from burns, ulcers, or surgical procedures. It can be applied in various clinical settings, often in combination with other therapies like negative pressure wound therapy (NPWT), to enhance healing outcomes and improve patient comfort and satisfaction.
The global Micronized Acellular Dermal Matrix (mADM) revenue was US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of %during the review period (2024-2030).
In United States the Micronized Acellular Dermal Matrix (mADM) revenue is expected to grow from US$ million in 2023 to US$ million by 2030, at a CAGR of % during the forecast period (2024-2030).
This report focuses on global and United States Micronized Acellular Dermal Matrix (mADM) market, also covers the segmentation data of other regions in regional level and county level.
The global key players of Micronized Acellular Dermal Matrix (mADM) include AlloDerm (AbbVie), CG Bio, Unitrump, Lthink, etc. The global five biggest players hold a share of % in 2023.
Global Micronized Acellular Dermal Matrix (mADM) Scope and Market Size
Micronized Acellular Dermal Matrix (mADM) market is segmented in regional and country level, by players, by Type, and by Application. Players, stakeholders, and other participants in the global Micronized Acellular Dermal Matrix (mADM) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2019-2030.
For United States market, this report focuses on the Micronized Acellular Dermal Matrix (mADM) market size by players, by Type, and by Application, for the period 2019-2030. The key players include the global and local players which play important roles in United States.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Introduces Micronized Acellular Dermal Matrix (mADM) definition, global market size, United States market size, United States percentage in global market. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Detailed analysis of Micronized Acellular Dermal Matrix (mADM) companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Revenue of Micronized Acellular Dermal Matrix (mADM) in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 6: Americas by Type, by Application and by country, revenue for each segment.
Chapter 7: EMEA by Type, by Application and by region, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: APAC (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Micronized Acellular Dermal Matrix (mADM) revenue, gross margin, and recent development, etc.
Chapter 11: Analyst's Viewpoints/Conclusion
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Study Coverage
1.1 Micronized Acellular Dermal Matrix (mADM) Product Introduction
1.2 Global Micronized Acellular Dermal Matrix (mADM) Outlook, 2019 VS 2023 VS 2030
1.2.1 Global Micronized Acellular Dermal Matrix (mADM) Market Size for the Year 2019-2030
1.2.2 United States Micronized Acellular Dermal Matrix (mADM) Market Size for the Year 2019-2030
1.3 Micronized Acellular Dermal Matrix (mADM) Market Size, United States VS Global, 2019 VS 2023 VS 2030
1.3.1 The Market Share of United States Micronized Acellular Dermal Matrix (mADM) in Global, 2019 VS 2023 VS 2030
1.3.2 The Growth Rate of Micronized Acellular Dermal Matrix (mADM) Market Size, United States VS Global, 2019 VS 2023 VS 2030
1.4 Micronized Acellular Dermal Matrix (mADM) Market Dynamics
1.4.1 Micronized Acellular Dermal Matrix (mADM) Industry Trends
1.4.2 Micronized Acellular Dermal Matrix (mADM) Market Drivers
1.4.3 Micronized Acellular Dermal Matrix (mADM) Market Challenges
1.4.4 Micronized Acellular Dermal Matrix (mADM) Market Restraints
1.5 Assumptions and Limitations
1.6 Study Objectives
1.7 Years Considered
2 Micronized Acellular Dermal Matrix (mADM) by Type
2.1 Micronized Acellular Dermal Matrix (mADM) Market by Type
2.1.1 Allogeneic ADM (Human Origin)
2.1.2 Xenogeneic ADM (Animal Origin)
2.2 Global Micronized Acellular Dermal Matrix (mADM) Market Size by Type (2019, 2023 & 2030)
2.3 Global Micronized Acellular Dermal Matrix (mADM) Market Size by Type (2019-2030)
2.4 United States Micronized Acellular Dermal Matrix (mADM) Market Size by Type (2019, 2023 & 2030)
2.5 United States Micronized Acellular Dermal Matrix (mADM) Market Size by Type (2019-2030)
3 Micronized Acellular Dermal Matrix (mADM) by Application
3.1 Micronized Acellular Dermal Matrix (mADM) Market by Application
3.1.1 Tissue Repair
3.1.2 Plastic Surgery
3.1.3 Others
3.2 Global Micronized Acellular Dermal Matrix (mADM) Market Size, by Application (2019, 2023 & 2030)
3.3 Global Micronized Acellular Dermal Matrix (mADM) Market Size by Application (2019-2030)
3.4 United States Micronized Acellular Dermal Matrix (mADM) Market Size by Application (2019, 2023 & 2030)
3.5 United States Micronized Acellular Dermal Matrix (mADM) Market Size by Application (2019-2030)
4 Global Micronized Acellular Dermal Matrix (mADM) Competitor Landscape by Company
4.1 Global Micronized Acellular Dermal Matrix (mADM) Market Size by Company
4.1.1 Global Key Companies of Micronized Acellular Dermal Matrix (mADM), Ranked by Revenue (2023)
4.1.2 Global Micronized Acellular Dermal Matrix (mADM) Revenue by Player (2019-2024)
4.2 Global Micronized Acellular Dermal Matrix (mADM) Concentration Ratio (CR)
4.2.1 Micronized Acellular Dermal Matrix (mADM) Market Concentration Ratio (CR) (2019-2024)
4.2.2 Global Top 5 and Top 10 Largest Companies of Micronized Acellular Dermal Matrix (mADM) in 2023
4.2.3 Global Micronized Acellular Dermal Matrix (mADM) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Key Players of Micronized Acellular Dermal Matrix (mADM) Head office and Area Served
4.4 Global Key Players of Micronized Acellular Dermal Matrix (mADM), Product and Application
4.5 Global Key Players of Micronized Acellular Dermal Matrix (mADM), Date of Enter into This Industry
4.6 Companies Mergers & Acquisitions, Expansion Plans
4.7 United States Micronized Acellular Dermal Matrix (mADM) Market Size by Company
4.7.1 Key Players of Micronized Acellular Dermal Matrix (mADM) in United States, Ranked by Revenue (2023)
4.7.2 United States Micronized Acellular Dermal Matrix (mADM) Revenue by Players (2022, 2023 & 2024)
5 Global Micronized Acellular Dermal Matrix (mADM) Market Size by Region
5.1 Global Micronized Acellular Dermal Matrix (mADM) Market Size by Region: 2019 VS 2023 VS 2030
5.2 Global Micronized Acellular Dermal Matrix (mADM) Market Size by Region (2019-2030)
5.2.1 Global Micronized Acellular Dermal Matrix (mADM) Market Size by Region: 2019-2024
5.2.2 Global Micronized Acellular Dermal Matrix (mADM) Market Size by Region: 2025-2030
6 Americas
6.1 Americas Micronized Acellular Dermal Matrix (mADM) Market Size YoY Growth 2019-2030
6.2 Americas Micronized Acellular Dermal Matrix (mADM) Market Size by Type
6.2.1 Americas Micronized Acellular Dermal Matrix (mADM) Market Size by Type (2019-2024)
6.2.2 Americas Micronized Acellular Dermal Matrix (mADM) Market Size by Type (2025-2030)
6.2.3 Americas Micronized Acellular Dermal Matrix (mADM) Market Share by Type (2019-2030)
6.3 Americas Micronized Acellular Dermal Matrix (mADM) Market Size by Application
6.3.1 Americas Micronized Acellular Dermal Matrix (mADM) Market Size by Application (2019-2024)
6.3.2 Americas Micronized Acellular Dermal Matrix (mADM) Market Size by Application (2025-2030)
6.3.3 Americas Micronized Acellular Dermal Matrix (mADM) Market Share by Application (2019-2030)
6.4 Americas Micronized Acellular Dermal Matrix (mADM) Market Facts & Figures by Country (2019, 2023 & 2030)
6.4.1 United States
6.4.2 Canada
6.4.3 Mexico
6.4.4 Brazil
7 EMEA
7.1 EMEA Micronized Acellular Dermal Matrix (mADM) Market Size YoY Growth 2019-2030
7.2 EMEA Micronized Acellular Dermal Matrix (mADM) Market Size by Type
7.2.1 EMEA Micronized Acellular Dermal Matrix (mADM) Market Size by Type (2019-2024)
7.2.2 EMEA Micronized Acellular Dermal Matrix (mADM) Market Size by Type (2025-2030)
7.2.3 EMEA Micronized Acellular Dermal Matrix (mADM) Market Share by Type (2019-2030)
7.3 EMEA Micronized Acellular Dermal Matrix (mADM) Market Size by Application
7.3.1 EMEA Micronized Acellular Dermal Matrix (mADM) Market Size by Application (2019-2024)
7.3.2 EMEA Micronized Acellular Dermal Matrix (mADM) Market Size by Application (2025-2030)
7.3.3 EMEA Micronized Acellular Dermal Matrix (mADM) Market Share by Application (2019-2030)
7.4 EMEA Micronized Acellular Dermal Matrix (mADM) Market Facts & Figures by Region (2019, 2023 & 2030)
7.4.1 Europe
7.4.2 Middle East
7.4.3 Africa
8 China
8.1 China Micronized Acellular Dermal Matrix (mADM) Market Size by Type
8.1.1 China Micronized Acellular Dermal Matrix (mADM) Market Size by Type (2019-2024)
8.1.2 China Micronized Acellular Dermal Matrix (mADM) Market Size by Type (2025-2030)
8.1.3 China Micronized Acellular Dermal Matrix (mADM) Market Share by Type (2019-2030)
8.2 China Micronized Acellular Dermal Matrix (mADM) Market Size by Application
8.2.1 China Micronized Acellular Dermal Matrix (mADM) Market Size by Application (2019-2024)
8.2.2 China Micronized Acellular Dermal Matrix (mADM) Market Size by Application (2025-2030)
8.2.3 China Micronized Acellular Dermal Matrix (mADM) Market Share by Application (2019-2030)
9 APAC (excluding China)
9.1 APAC Micronized Acellular Dermal Matrix (mADM) Market Size YoY Growth 2019-2030
9.2 APAC Micronized Acellular Dermal Matrix (mADM) Market Size by Type
9.2.1 APAC Micronized Acellular Dermal Matrix (mADM) Market Size by Type (2019-2024)
9.2.2 APAC Micronized Acellular Dermal Matrix (mADM) Market Size by Type (2025-2030)
9.2.3 APAC Micronized Acellular Dermal Matrix (mADM) Market Share by Type (2019-2030)
9.3 APAC Micronized Acellular Dermal Matrix (mADM) Market Size by Application
9.3.1 APAC Micronized Acellular Dermal Matrix (mADM) Market Size by Application (2019-2024)
9.3.2 APAC Micronized Acellular Dermal Matrix (mADM) Market Size by Application (2025-2030)
9.3.3 APAC Micronized Acellular Dermal Matrix (mADM) Market Share by Application (2019-2030)
9.4 APAC Micronized Acellular Dermal Matrix (mADM) Market Facts & Figures by Region (2019, 2023 & 2030)
9.4.1 Japan
9.4.2 South Korea
9.4.3 China Taiwan
9.4.4 ASEAN
9.4.5 India
10 Key Players Profiles
10.1 AlloDerm (AbbVie)
10.1.1 AlloDerm (AbbVie) Company Details
10.1.2 AlloDerm (AbbVie) Business Overview
10.1.3 AlloDerm (AbbVie) Micronized Acellular Dermal Matrix (mADM) Introduction
10.1.4 AlloDerm (AbbVie) Revenue in Micronized Acellular Dermal Matrix (mADM) Business (2019-2024)
10.1.5 AlloDerm (AbbVie) Recent Development
10.2 CG Bio
10.2.1 CG Bio Company Details
10.2.2 CG Bio Business Overview
10.2.3 CG Bio Micronized Acellular Dermal Matrix (mADM) Introduction
10.2.4 CG Bio Revenue in Micronized Acellular Dermal Matrix (mADM) Business (2019-2024)
10.2.5 CG Bio Recent Development
10.3 Unitrump
10.3.1 Unitrump Company Details
10.3.2 Unitrump Business Overview
10.3.3 Unitrump Micronized Acellular Dermal Matrix (mADM) Introduction
10.3.4 Unitrump Revenue in Micronized Acellular Dermal Matrix (mADM) Business (2019-2024)
10.3.5 Unitrump Recent Development
10.4 Lthink
10.4.1 Lthink Company Details
10.4.2 Lthink Business Overview
10.4.3 Lthink Micronized Acellular Dermal Matrix (mADM) Introduction
10.4.4 Lthink Revenue in Micronized Acellular Dermal Matrix (mADM) Business (2019-2024)
10.4.5 Lthink Recent Development
11 Research Findings and Conclusion
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.1.1 Research Programs/Design
12.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
12.1.2 Data Source
12.1.2.1 Secondary Sources
12.1.2.2 Primary Sources
12.2 Author Details
12.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Micronized Acellular Dermal Matrix (mADM) market is projected to grow from US$ million in 2025 to US$ million by 2032, at a CAGR of %(2026-2032), driven by critical product segments and diverse end‑use applications.
Published Date: 2026-03-26
Pages: 115
USD 4900.00
(Single User License)
The global Micronized Acellular Dermal Matrix (mADM) market size was US$ million in 2025 and is forecast to reach a readjusted size of US$ million by 2032 with a CAGR of %during the forecast period 2026-2032.
Published Date: 2026-03-26
Pages: 74
USD 4250.00
(Single User License)
The global Micronized Acellular Dermal Matrix (mADM) market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-01-09
Pages: 93
USD 2900.00
(Single User License)
The global market for Micronized Acellular Dermal Matrix (mADM) was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-01-09
Pages: 77
USD 3950.00
(Single User License)
The global Micronized Acellular Dermal Matrix (mADM) market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
Published Date: 2025-08-05
Pages: 104
USD 4900.00
(Single User License)
The global Micronized Acellular Dermal Matrix (mADM) market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-08-01
Pages: 73
USD 4250.00
(Single User License)
The global market for Micronized Acellular Dermal Matrix (mADM) was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-03-10
Pages: 72
USD 3950.00
(Single User License)
The global market for Micronized Acellular Dermal Matrix (mADM) was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-03-10
Pages: 61
USD 2900.00
(Single User License)
Micronized Acellular Dermal Matrix (mADM) is a biocompatible material derived from human or animal dermis, which has been processed to remove cellular components while preserving the extracellular matrix structure. The micronization process involves breaking down the acellular dermal matrix into smaller particles, which can be formulated into a paste or injectable form. This matrix serves as a scaffold that supports tissue regeneration and repair by promoting cell infiltration and neovascularization. mADM is particularly used in wound healing, as it provides a structural framework that facilitates the closure of difficult-to-heal wounds, such as those resulting from burns, ulcers, or surgical procedures. It can be applied in various clinical settings, often in combination with other therapies like negative pressure wound therapy (NPWT), to enhance healing outcomes and improve patient comfort and satisfaction.
Published Date: 2024-08-16
Pages: 104
USD 4900.00
(Single User License)
Micronized Acellular Dermal Matrix (mADM) is a biocompatible material derived from human or animal dermis, which has been processed to remove cellular components while preserving the extracellular matrix structure. The micronization process involves breaking down the acellular dermal matrix into smaller particles, which can be formulated into a paste or injectable form. This matrix serves as a scaffold that supports tissue regeneration and repair by promoting cell infiltration and neovascularization. mADM is particularly used in wound healing, as it provides a structural framework that facilitates the closure of difficult-to-heal wounds, such as those resulting from burns, ulcers, or surgical procedures. It can be applied in various clinical settings, often in combination with other therapies like negative pressure wound therapy (NPWT), to enhance healing outcomes and improve patient comfort and satisfaction.
Published Date: 2024-08-16
Pages: 73
USD 3950.00
(Single User License)
The global Micronized Acellular Dermal Matrix (mADM) market is projected to grow from US$ million in 2025 to US$ million by 2032, at a CAGR of %(2026-2032), driven by critical product segments and diverse end‑use applications.
Published: 2026-03-26
Pages: 115
The global Micronized Acellular Dermal Matrix (mADM) market size was US$ million in 2025 and is forecast to reach a readjusted size of US$ million by 2032 with a CAGR of %during the forecast period 2026-2032.
Published: 2026-03-26
Pages: 74
The global Micronized Acellular Dermal Matrix (mADM) market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-01-09
Pages: 93
The global market for Micronized Acellular Dermal Matrix (mADM) was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-01-09
Pages: 77
The global Micronized Acellular Dermal Matrix (mADM) market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
Published: 2025-08-05
Pages: 104
The global Micronized Acellular Dermal Matrix (mADM) market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-08-01
Pages: 73
The global market for Micronized Acellular Dermal Matrix (mADM) was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-03-10
Pages: 72
The global market for Micronized Acellular Dermal Matrix (mADM) was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-03-10
Pages: 61
Micronized Acellular Dermal Matrix (mADM) is a biocompatible material derived from human or animal dermis, which has been processed to remove cellular components while preserving the extracellular matrix structure. The micronization process involves breaking down the acellular dermal matrix into smaller particles, which can be formulated into a paste or injectable form. This matrix serves as a scaffold that supports tissue regeneration and repair by promoting cell infiltration and neovascularization. mADM is particularly used in wound healing, as it provides a structural framework that facilitates the closure of difficult-to-heal wounds, such as those resulting from burns, ulcers, or surgical procedures. It can be applied in various clinical settings, often in combination with other therapies like negative pressure wound therapy (NPWT), to enhance healing outcomes and improve patient comfort and satisfaction.
Published: 2024-08-16
Pages: 104
Micronized Acellular Dermal Matrix (mADM) is a biocompatible material derived from human or animal dermis, which has been processed to remove cellular components while preserving the extracellular matrix structure. The micronization process involves breaking down the acellular dermal matrix into smaller particles, which can be formulated into a paste or injectable form. This matrix serves as a scaffold that supports tissue regeneration and repair by promoting cell infiltration and neovascularization. mADM is particularly used in wound healing, as it provides a structural framework that facilitates the closure of difficult-to-heal wounds, such as those resulting from burns, ulcers, or surgical procedures. It can be applied in various clinical settings, often in combination with other therapies like negative pressure wound therapy (NPWT), to enhance healing outcomes and improve patient comfort and satisfaction.
Published: 2024-08-16
Pages: 73
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now